Streamlined Pre-IND Strategy​

Streamlined FDA Pre-IND submission through cross-functional regulatory strategy in Phase 1 cell therapy development.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

OCT Europe 2026

6th May 2026 to 7th May 2026
Hyatt Regency Barcelona Tower

02/17/2026

Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

RALEIGH, N.C.; February 17, 2026 – Caidya, a leading global,...

02/10/2026

Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe

RALEIGH, N.C.; Feb 10, 2026 – Caidya, a leading global, mid-sized CRO focused on accelerating...
Skip to toolbar